Acute Myelogenous Leukemia
Showing 51 - 75 of 203
Acute Myelogenous Leukemia Trial in Philadelphia (Birinapant)
Terminated
- Acute Myelogenous Leukemia
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 23, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,
Recruiting
- Acute Myelogenous Leukemia
- +17 more
- Allopurinol
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
May 21, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,
Completed
- Acute Lymphoblastic Leukemia
- +3 more
- total body irradiation
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 17, 2021
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)
Active, not recruiting
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
- MCLA-117 bispecific antibody
-
Augusta, Georgia
- +9 more
May 6, 2021
Acute Myelogenous Leukemia Trial in Fuzhou, Shanghai (SH1573 Capsules)
Recruiting
- Acute Myelogenous Leukemia
- SH1573 Capsules
-
Fuzhou, Fujian, China
- +1 more
Mar 17, 2021
Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia Trial in Washington, Bethesda, Oklahoma City
Completed
- Myelodysplastic Syndrome
- +4 more
- First Allogeneic Bone Marrow Transplant (BMT)
- +9 more
-
Washington, District of Columbia
- +2 more
Mar 16, 2021
Acute Myelogenous Leukemia Trial in United States (KIR genotype)
Completed
- Acute Myelogenous Leukemia
- KIR genotype
-
Scottsdale, Arizona
- +18 more
Mar 9, 2021
Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)
Completed
- Acute Myelogenous Leukemia
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
Feb 4, 2021
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)
Terminated
- Acute Lymphoblastic Leukemia
- +17 more
- Infusion of Treg
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Sep 8, 2020
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated
Terminated
- Chronic Myelogenous Leukemia
- +7 more
- CD3/CD28 Activated T cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 12, 2020
Acute Myelogenous Leukemia, Allogeneic Stem Cell Transplantation Trial in Ramat Gan (Bisantrene)
Completed
- Acute Myelogenous Leukemia
- Allogeneic Stem Cell Transplantation
-
Ramat Gan, IsraelChaim Sheba Medical Center
Aug 6, 2020
Acute Myelogenous Leukemia, MDS Trial in Petach Tikva, Re?ovot (Nerofe, Doxorubicin)
Withdrawn
- Acute Myelogenous Leukemia
- Myelodysplastic Syndromes
-
Petach Tikva, Israel
- +1 more
Jul 29, 2020
Acute Myelogenous Leukemia, MDS, Leukemia Trial in Miami (Tranylcypromine, Tretinoin)
Completed
- Acute Myelogenous Leukemia
- +2 more
-
Miami, FloridaUniversity of Miami
Jul 20, 2020
Acute Myelogenous Leukemia Trial in Chicago, Minneapolis, Columbus (Interventions)
Terminated
- Acute Myelogenous Leukemia
- Interventions
-
Chicago, Illinois
- +2 more
Jul 8, 2020
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC
Completed
- Acute Myelogenous Leukemia
- +3 more
- Infusion of one MPC expanded cord unit and one unexpanded cord unit
- Infusion of two unexpanded cord blood units.
-
Miami, Florida
- +8 more
Jun 25, 2020
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Tetanus
-
Houston, Texas
- +1 more
Apr 20, 2020
Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)
Completed
- Acute Myelogenous Leukemia
- Brentuximab Vedotin
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 12, 2020
Acute Myelogenous Leukemia Trial in United States (MLN4924, Azacitidine)
Completed
- Acute Myelogenous Leukemia
-
Birmingham, Alabama
- +7 more
Feb 18, 2020
MDS, Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Gainesville (Molecular diagnostic testing)
Terminated
- Myelodysplastic Syndromes
- +6 more
- Molecular diagnostic testing
-
Gainesville, FloridaUF Health Shands Cancer Hospital
Dec 18, 2019
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Belgium (Donor lymphocyte infusion, Azacytidine)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Donor lymphocyte infusion
- Azacytidine
-
Antwerpen, Belgium
- +11 more
Dec 6, 2019
Refractory or Recurrent Solid Tumors, Acute Myelogenous Leukemia Trial in Philadelphia (Cediranib, AZD2171, RECENTIN)
Completed
- Refractory or Recurrent Solid Tumors
- Acute Myelogenous Leukemia
- Cediranib, AZD2171, RECENTIN
-
Philadelphia, PennsylvaniaChildrens Hospital, Philadelphia
Nov 20, 2019
Acute Myelogenous Leukemia Trial in Greenville (Interleukin-2)
Terminated
- Acute Myelogenous Leukemia
-
Greenville, North CarolinaLeo W. Jenkins Cancer Center
Aug 20, 2019